nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—LYN—systemic lupus erythematosus	0.433	1	CbGaD
Ponatinib—ABCG2—Leflunomide—systemic lupus erythematosus	0.0276	0.0935	CbGbCtD
Ponatinib—ABCB11—Cyclosporine—systemic lupus erythematosus	0.0272	0.0921	CbGbCtD
Ponatinib—ABCB11—Dexamethasone—systemic lupus erythematosus	0.0179	0.0607	CbGbCtD
Ponatinib—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.017	0.0578	CbGbCtD
Ponatinib—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0137	0.0464	CbGbCtD
Ponatinib—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0129	0.0438	CbGbCtD
Ponatinib—CYP3A5—Dapsone—systemic lupus erythematosus	0.0109	0.0369	CbGbCtD
Ponatinib—CYP2C8—Dapsone—systemic lupus erythematosus	0.0105	0.0355	CbGbCtD
Ponatinib—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.00944	0.032	CbGbCtD
Ponatinib—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.00908	0.0308	CbGbCtD
Ponatinib—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0085	0.0288	CbGbCtD
Ponatinib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00811	0.0275	CbGbCtD
Ponatinib—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.00758	0.0257	CbGbCtD
Ponatinib—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00728	0.0247	CbGbCtD
Ponatinib—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00716	0.0243	CbGbCtD
Ponatinib—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00688	0.0233	CbGbCtD
Ponatinib—ABCG2—Methotrexate—systemic lupus erythematosus	0.00683	0.0232	CbGbCtD
Ponatinib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00614	0.0208	CbGbCtD
Ponatinib—ABCB1—Betamethasone—systemic lupus erythematosus	0.00527	0.0179	CbGbCtD
Ponatinib—ABCB1—Prednisolone—systemic lupus erythematosus	0.0052	0.0176	CbGbCtD
Ponatinib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00493	0.0167	CbGbCtD
Ponatinib—ABCB1—Prednisone—systemic lupus erythematosus	0.00491	0.0167	CbGbCtD
Ponatinib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00486	0.0165	CbGbCtD
Ponatinib—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00471	0.016	CbGbCtD
Ponatinib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00466	0.0158	CbGbCtD
Ponatinib—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00453	0.0154	CbGbCtD
Ponatinib—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00439	0.0149	CbGbCtD
Ponatinib—CYP3A4—Dapsone—systemic lupus erythematosus	0.00425	0.0144	CbGbCtD
Ponatinib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00368	0.0125	CbGbCtD
Ponatinib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00368	0.0125	CbGbCtD
Ponatinib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00316	0.0107	CbGbCtD
Ponatinib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00312	0.0106	CbGbCtD
Ponatinib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00307	0.0104	CbGbCtD
Ponatinib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00295	0.01	CbGbCtD
Ponatinib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00294	0.00998	CbGbCtD
Ponatinib—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00289	0.0098	CbGbCtD
Ponatinib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00279	0.00946	CbGbCtD
Ponatinib—FGFR4—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.00268	1	CbGdCrCtD
Ponatinib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00246	0.00835	CbGbCtD
Ponatinib—Nilotinib—LYN—systemic lupus erythematosus	0.00208	0.609	CrCbGaD
Ponatinib—KDR—umbilical vein—systemic lupus erythematosus	0.00197	0.0318	CbGeAlD
Ponatinib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00184	0.00623	CbGbCtD
Ponatinib—LYN—blood plasma—systemic lupus erythematosus	0.00162	0.0262	CbGeAlD
Ponatinib—BCR—blood plasma—systemic lupus erythematosus	0.0014	0.0226	CbGeAlD
Ponatinib—FLT3—blood plasma—systemic lupus erythematosus	0.00139	0.0224	CbGeAlD
Ponatinib—FGFR4—connective tissue—systemic lupus erythematosus	0.00126	0.0203	CbGeAlD
Ponatinib—FGFR4—nephron tubule—systemic lupus erythematosus	0.00122	0.0197	CbGeAlD
Ponatinib—Nilotinib—BLK—systemic lupus erythematosus	0.0012	0.35	CrCbGaD
Ponatinib—TEK—endothelium—systemic lupus erythematosus	0.00114	0.0184	CbGeAlD
Ponatinib—FGFR4—kidney—systemic lupus erythematosus	0.00107	0.0173	CbGeAlD
Ponatinib—FGFR4—cortex of kidney—systemic lupus erythematosus	0.00105	0.0169	CbGeAlD
Ponatinib—SRC—endothelium—systemic lupus erythematosus	0.00101	0.0164	CbGeAlD
Ponatinib—KDR—endothelium—systemic lupus erythematosus	0.000933	0.0151	CbGeAlD
Ponatinib—SRC—blood plasma—systemic lupus erythematosus	0.000901	0.0145	CbGeAlD
Ponatinib—LYN—connective tissue—systemic lupus erythematosus	0.000865	0.014	CbGeAlD
Ponatinib—FGFR3—connective tissue—systemic lupus erythematosus	0.00086	0.0139	CbGeAlD
Ponatinib—KDR—blood plasma—systemic lupus erythematosus	0.000829	0.0134	CbGeAlD
Ponatinib—KIT—endothelium—systemic lupus erythematosus	0.000827	0.0133	CbGeAlD
Ponatinib—FGFR3—skin of body—systemic lupus erythematosus	0.000777	0.0125	CbGeAlD
Ponatinib—FGFR4—lung—systemic lupus erythematosus	0.000761	0.0123	CbGeAlD
Ponatinib—FLT3—connective tissue—systemic lupus erythematosus	0.000739	0.0119	CbGeAlD
Ponatinib—KIT—blood plasma—systemic lupus erythematosus	0.000735	0.0118	CbGeAlD
Ponatinib—FGFR3—kidney—systemic lupus erythematosus	0.000732	0.0118	CbGeAlD
Ponatinib—BCR—nephron tubule—systemic lupus erythematosus	0.000721	0.0116	CbGeAlD
Ponatinib—FGFR3—cortex of kidney—systemic lupus erythematosus	0.000713	0.0115	CbGeAlD
Ponatinib—FGFR4—nervous system—systemic lupus erythematosus	0.000704	0.0114	CbGeAlD
Ponatinib—FGFR4—central nervous system—systemic lupus erythematosus	0.000678	0.0109	CbGeAlD
Ponatinib—LYN—lymphoid tissue—systemic lupus erythematosus	0.000632	0.0102	CbGeAlD
Ponatinib—BCR—cortex of kidney—systemic lupus erythematosus	0.000617	0.00996	CbGeAlD
Ponatinib—RET—connective tissue—systemic lupus erythematosus	0.000593	0.00956	CbGeAlD
Ponatinib—FGFR2—connective tissue—systemic lupus erythematosus	0.000563	0.00908	CbGeAlD
Ponatinib—FGFR1—cortex of kidney—systemic lupus erythematosus	0.000549	0.00886	CbGeAlD
Ponatinib—BCR—lymphoid tissue—systemic lupus erythematosus	0.000544	0.00878	CbGeAlD
Ponatinib—FLT3—lymphoid tissue—systemic lupus erythematosus	0.00054	0.00872	CbGeAlD
Ponatinib—TEK—connective tissue—systemic lupus erythematosus	0.00054	0.00871	CbGeAlD
Ponatinib—CYP3A4—urine—systemic lupus erythematosus	0.000538	0.00868	CbGeAlD
Ponatinib—CYP2D6—urine—systemic lupus erythematosus	0.00053	0.00854	CbGeAlD
Ponatinib—FGFR3—lung—systemic lupus erythematosus	0.000519	0.00837	CbGeAlD
Ponatinib—BCR—tendon—systemic lupus erythematosus	0.000512	0.00825	CbGeAlD
Ponatinib—FGFR2—skin of body—systemic lupus erythematosus	0.000509	0.0082	CbGeAlD
Ponatinib—RET—kidney—systemic lupus erythematosus	0.000505	0.00814	CbGeAlD
Ponatinib—BCR—bone marrow—systemic lupus erythematosus	0.000496	0.008	CbGeAlD
Ponatinib—FLT3—bone marrow—systemic lupus erythematosus	0.000492	0.00794	CbGeAlD
Ponatinib—PDGFRA—connective tissue—systemic lupus erythematosus	0.000489	0.00789	CbGeAlD
Ponatinib—LYN—nervous system—systemic lupus erythematosus	0.000483	0.00779	CbGeAlD
Ponatinib—FGFR3—nervous system—systemic lupus erythematosus	0.000481	0.00775	CbGeAlD
Ponatinib—SRC—connective tissue—systemic lupus erythematosus	0.00048	0.00774	CbGeAlD
Ponatinib—FGFR2—kidney—systemic lupus erythematosus	0.000479	0.00773	CbGeAlD
Ponatinib—LYN—central nervous system—systemic lupus erythematosus	0.000465	0.0075	CbGeAlD
Ponatinib—FGFR3—central nervous system—systemic lupus erythematosus	0.000463	0.00746	CbGeAlD
Ponatinib—TEK—kidney—systemic lupus erythematosus	0.00046	0.00741	CbGeAlD
Ponatinib—FGFR1—tendon—systemic lupus erythematosus	0.000455	0.00734	CbGeAlD
Ponatinib—BCR—lung—systemic lupus erythematosus	0.000449	0.00724	CbGeAlD
Ponatinib—TEK—cortex of kidney—systemic lupus erythematosus	0.000448	0.00722	CbGeAlD
Ponatinib—FLT3—lung—systemic lupus erythematosus	0.000446	0.00719	CbGeAlD
Ponatinib—KDR—connective tissue—systemic lupus erythematosus	0.000441	0.00712	CbGeAlD
Ponatinib—RET—lymphoid tissue—systemic lupus erythematosus	0.000433	0.00699	CbGeAlD
Ponatinib—SRC—skin of body—systemic lupus erythematosus	0.000433	0.00699	CbGeAlD
Ponatinib—KDR—nephron tubule—systemic lupus erythematosus	0.000427	0.0069	CbGeAlD
Ponatinib—BCR—nervous system—systemic lupus erythematosus	0.000416	0.00671	CbGeAlD
Ponatinib—CYP2C8—blood plasma—systemic lupus erythematosus	0.000415	0.00669	CbGeAlD
Ponatinib—SRC—kidney—systemic lupus erythematosus	0.000408	0.00659	CbGeAlD
Ponatinib—RET—tendon—systemic lupus erythematosus	0.000407	0.00657	CbGeAlD
Ponatinib—BCR—central nervous system—systemic lupus erythematosus	0.0004	0.00646	CbGeAlD
Ponatinib—FGFR1—lung—systemic lupus erythematosus	0.0004	0.00644	CbGeAlD
Ponatinib—TEK—lymphoid tissue—systemic lupus erythematosus	0.000395	0.00637	CbGeAlD
Ponatinib—LCK—bone marrow—systemic lupus erythematosus	0.000395	0.00637	CbGeAlD
Ponatinib—KIT—connective tissue—systemic lupus erythematosus	0.000391	0.00631	CbGeAlD
Ponatinib—KIT—nephron tubule—systemic lupus erythematosus	0.000379	0.00611	CbGeAlD
Ponatinib—KDR—kidney—systemic lupus erythematosus	0.000376	0.00606	CbGeAlD
Ponatinib—CYP3A5—blood plasma—systemic lupus erythematosus	0.000374	0.00604	CbGeAlD
Ponatinib—TEK—tendon—systemic lupus erythematosus	0.000371	0.00599	CbGeAlD
Ponatinib—KDR—cortex of kidney—systemic lupus erythematosus	0.000366	0.0059	CbGeAlD
Ponatinib—PDGFRA—lymphoid tissue—systemic lupus erythematosus	0.000358	0.00577	CbGeAlD
Ponatinib—LCK—lung—systemic lupus erythematosus	0.000358	0.00577	CbGeAlD
Ponatinib—KIT—skin of body—systemic lupus erythematosus	0.000353	0.0057	CbGeAlD
Ponatinib—SRC—lymphoid tissue—systemic lupus erythematosus	0.000351	0.00566	CbGeAlD
Ponatinib—ABL1—connective tissue—systemic lupus erythematosus	0.00034	0.00549	CbGeAlD
Ponatinib—FGFR2—lung—systemic lupus erythematosus	0.00034	0.00548	CbGeAlD
Ponatinib—PDGFRA—tendon—systemic lupus erythematosus	0.000336	0.00542	CbGeAlD
Ponatinib—KIT—kidney—systemic lupus erythematosus	0.000333	0.00537	CbGeAlD
Ponatinib—RET—nervous system—systemic lupus erythematosus	0.000331	0.00534	CbGeAlD
Ponatinib—ABL1—nephron tubule—systemic lupus erythematosus	0.00033	0.00532	CbGeAlD
Ponatinib—TEK—lung—systemic lupus erythematosus	0.000326	0.00525	CbGeAlD
Ponatinib—KIT—cortex of kidney—systemic lupus erythematosus	0.000324	0.00523	CbGeAlD
Ponatinib—KDR—lymphoid tissue—systemic lupus erythematosus	0.000323	0.0052	CbGeAlD
Ponatinib—RET—central nervous system—systemic lupus erythematosus	0.000319	0.00514	CbGeAlD
Ponatinib—FGFR2—nervous system—systemic lupus erythematosus	0.000315	0.00507	CbGeAlD
Ponatinib—ABL1—skin of body—systemic lupus erythematosus	0.000307	0.00496	CbGeAlD
Ponatinib—KDR—tendon—systemic lupus erythematosus	0.000303	0.00489	CbGeAlD
Ponatinib—FGFR2—central nervous system—systemic lupus erythematosus	0.000303	0.00489	CbGeAlD
Ponatinib—TEK—nervous system—systemic lupus erythematosus	0.000302	0.00487	CbGeAlD
Ponatinib—PDGFRA—lung—systemic lupus erythematosus	0.000295	0.00476	CbGeAlD
Ponatinib—KDR—bone marrow—systemic lupus erythematosus	0.000294	0.00474	CbGeAlD
Ponatinib—TEK—central nervous system—systemic lupus erythematosus	0.00029	0.00468	CbGeAlD
Ponatinib—ABL1—kidney—systemic lupus erythematosus	0.00029	0.00467	CbGeAlD
Ponatinib—SRC—lung—systemic lupus erythematosus	0.000289	0.00467	CbGeAlD
Ponatinib—KIT—lymphoid tissue—systemic lupus erythematosus	0.000286	0.00461	CbGeAlD
Ponatinib—ABL1—cortex of kidney—systemic lupus erythematosus	0.000282	0.00455	CbGeAlD
Ponatinib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000281	0.00453	CbGeAlD
Ponatinib—CYP2D6—blood plasma—systemic lupus erythematosus	0.000276	0.00446	CbGeAlD
Ponatinib—PDGFRA—nervous system—systemic lupus erythematosus	0.000273	0.00441	CbGeAlD
Ponatinib—SRC—nervous system—systemic lupus erythematosus	0.000268	0.00432	CbGeAlD
Ponatinib—KDR—lung—systemic lupus erythematosus	0.000266	0.00429	CbGeAlD
Ponatinib—PDGFRA—central nervous system—systemic lupus erythematosus	0.000263	0.00424	CbGeAlD
Ponatinib—KIT—bone marrow—systemic lupus erythematosus	0.00026	0.0042	CbGeAlD
Ponatinib—SRC—central nervous system—systemic lupus erythematosus	0.000258	0.00416	CbGeAlD
Ponatinib—ABL1—lymphoid tissue—systemic lupus erythematosus	0.000249	0.00402	CbGeAlD
Ponatinib—KDR—nervous system—systemic lupus erythematosus	0.000246	0.00398	CbGeAlD
Ponatinib—KDR—central nervous system—systemic lupus erythematosus	0.000237	0.00383	CbGeAlD
Ponatinib—KIT—lung—systemic lupus erythematosus	0.000236	0.00381	CbGeAlD
Ponatinib—ABL1—tendon—systemic lupus erythematosus	0.000234	0.00377	CbGeAlD
Ponatinib—ABL1—bone marrow—systemic lupus erythematosus	0.000227	0.00366	CbGeAlD
Ponatinib—KIT—nervous system—systemic lupus erythematosus	0.000218	0.00352	CbGeAlD
Ponatinib—KIT—central nervous system—systemic lupus erythematosus	0.00021	0.00339	CbGeAlD
Ponatinib—ABCG2—nephron tubule—systemic lupus erythematosus	0.000208	0.00335	CbGeAlD
Ponatinib—ABL1—lung—systemic lupus erythematosus	0.000205	0.00331	CbGeAlD
Ponatinib—ABCB1—blood plasma—systemic lupus erythematosus	0.000199	0.00321	CbGeAlD
Ponatinib—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000193	0.00311	CbGeAlD
Ponatinib—ABL1—nervous system—systemic lupus erythematosus	0.00019	0.00307	CbGeAlD
Ponatinib—CYP2C8—kidney—systemic lupus erythematosus	0.000188	0.00303	CbGeAlD
Ponatinib—ABL1—central nervous system—systemic lupus erythematosus	0.000183	0.00295	CbGeAlD
Ponatinib—CYP3A5—kidney—systemic lupus erythematosus	0.00017	0.00274	CbGeAlD
Ponatinib—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000165	0.00267	CbGeAlD
Ponatinib—ABCG2—bone marrow—systemic lupus erythematosus	0.000143	0.00231	CbGeAlD
Ponatinib—Imatinib—ALB—systemic lupus erythematosus	0.000143	0.0417	CrCbGaD
Ponatinib—ABCG2—lung—systemic lupus erythematosus	0.000129	0.00209	CbGeAlD
Ponatinib—CYP3A4—kidney—systemic lupus erythematosus	0.000127	0.00205	CbGeAlD
Ponatinib—CYP2D6—kidney—systemic lupus erythematosus	0.000125	0.00202	CbGeAlD
Ponatinib—CYP3A5—lung—systemic lupus erythematosus	0.00012	0.00194	CbGeAlD
Ponatinib—ABCB1—nephron tubule—systemic lupus erythematosus	0.000103	0.00165	CbGeAlD
Ponatinib—ABCB1—kidney—systemic lupus erythematosus	9.01e-05	0.00145	CbGeAlD
Ponatinib—ABCB1—cortex of kidney—systemic lupus erythematosus	8.78e-05	0.00142	CbGeAlD
Ponatinib—CYP3A4—nervous system—systemic lupus erythematosus	8.35e-05	0.00135	CbGeAlD
Ponatinib—CYP2D6—nervous system—systemic lupus erythematosus	8.22e-05	0.00133	CbGeAlD
Ponatinib—CYP3A4—central nervous system—systemic lupus erythematosus	8.04e-05	0.0013	CbGeAlD
Ponatinib—CYP2D6—central nervous system—systemic lupus erythematosus	7.91e-05	0.00128	CbGeAlD
Ponatinib—ABCB1—lymphoid tissue—systemic lupus erythematosus	7.74e-05	0.00125	CbGeAlD
Ponatinib—ABCB1—bone marrow—systemic lupus erythematosus	7.05e-05	0.00114	CbGeAlD
Ponatinib—ABCB1—lung—systemic lupus erythematosus	6.39e-05	0.00103	CbGeAlD
Ponatinib—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	6.24e-05	0.000723	CcSEcCtD
Ponatinib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	6.24e-05	0.000723	CcSEcCtD
Ponatinib—Fatigue—Cyclosporine—systemic lupus erythematosus	6.23e-05	0.000722	CcSEcCtD
Ponatinib—Headache—Azathioprine—systemic lupus erythematosus	6.21e-05	0.00072	CcSEcCtD
Ponatinib—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	6.21e-05	0.00072	CcSEcCtD
Ponatinib—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	6.21e-05	0.000719	CcSEcCtD
Ponatinib—Dizziness—Leflunomide—systemic lupus erythematosus	6.19e-05	0.000718	CcSEcCtD
Ponatinib—Pain—Cyclosporine—systemic lupus erythematosus	6.18e-05	0.000716	CcSEcCtD
Ponatinib—Constipation—Cyclosporine—systemic lupus erythematosus	6.18e-05	0.000716	CcSEcCtD
Ponatinib—Dry mouth—Triamcinolone—systemic lupus erythematosus	6.17e-05	0.000715	CcSEcCtD
Ponatinib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	6.13e-05	0.00071	CcSEcCtD
Ponatinib—Stomatitis—Methotrexate—systemic lupus erythematosus	6.11e-05	0.000708	CcSEcCtD
Ponatinib—Angiopathy—Prednisone—systemic lupus erythematosus	6.1e-05	0.000707	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	6.09e-05	0.000706	CcSEcCtD
Ponatinib—Oedema—Triamcinolone—systemic lupus erythematosus	6.05e-05	0.000701	CcSEcCtD
Ponatinib—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	6.03e-05	0.000699	CcSEcCtD
Ponatinib—Pain—Mycophenolate mofetil—systemic lupus erythematosus	6.03e-05	0.000699	CcSEcCtD
Ponatinib—Arrhythmia—Prednisone—systemic lupus erythematosus	6.01e-05	0.000697	CcSEcCtD
Ponatinib—Infection—Triamcinolone—systemic lupus erythematosus	6.01e-05	0.000696	CcSEcCtD
Ponatinib—Infection—Methylprednisolone—systemic lupus erythematosus	6e-05	0.000695	CcSEcCtD
Ponatinib—Vomiting—Leflunomide—systemic lupus erythematosus	5.96e-05	0.00069	CcSEcCtD
Ponatinib—Insomnia—Prednisolone—systemic lupus erythematosus	5.95e-05	0.000689	CcSEcCtD
Ponatinib—Alopecia—Prednisone—systemic lupus erythematosus	5.95e-05	0.000689	CcSEcCtD
Ponatinib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	5.92e-05	0.000686	CcSEcCtD
Ponatinib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	5.92e-05	0.000686	CcSEcCtD
Ponatinib—ABCB1—nervous system—systemic lupus erythematosus	5.91e-05	0.000954	CbGeAlD
Ponatinib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	5.91e-05	0.000685	CcSEcCtD
Ponatinib—Epistaxis—Methotrexate—systemic lupus erythematosus	5.91e-05	0.000685	CcSEcCtD
Ponatinib—Paraesthesia—Prednisolone—systemic lupus erythematosus	5.91e-05	0.000685	CcSEcCtD
Ponatinib—Rash—Leflunomide—systemic lupus erythematosus	5.91e-05	0.000684	CcSEcCtD
Ponatinib—Dermatitis—Leflunomide—systemic lupus erythematosus	5.9e-05	0.000684	CcSEcCtD
Ponatinib—Mental disorder—Prednisone—systemic lupus erythematosus	5.89e-05	0.000683	CcSEcCtD
Ponatinib—Nausea—Azathioprine—systemic lupus erythematosus	5.89e-05	0.000683	CcSEcCtD
Ponatinib—Headache—Leflunomide—systemic lupus erythematosus	5.87e-05	0.00068	CcSEcCtD
Ponatinib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	5.86e-05	0.000679	CcSEcCtD
Ponatinib—Malnutrition—Prednisone—systemic lupus erythematosus	5.86e-05	0.000679	CcSEcCtD
Ponatinib—Erythema—Prednisone—systemic lupus erythematosus	5.86e-05	0.000679	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	5.85e-05	0.000678	CcSEcCtD
Ponatinib—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	5.85e-05	0.000678	CcSEcCtD
Ponatinib—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	5.83e-05	0.000676	CcSEcCtD
Ponatinib—Insomnia—Hydrocortisone—systemic lupus erythematosus	5.81e-05	0.000673	CcSEcCtD
Ponatinib—Hypertension—Betamethasone—systemic lupus erythematosus	5.81e-05	0.000673	CcSEcCtD
Ponatinib—Hypertension—Dexamethasone—systemic lupus erythematosus	5.81e-05	0.000673	CcSEcCtD
Ponatinib—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	5.77e-05	0.000669	CcSEcCtD
Ponatinib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.77e-05	0.000668	CcSEcCtD
Ponatinib—Myalgia—Dexamethasone—systemic lupus erythematosus	5.73e-05	0.000664	CcSEcCtD
Ponatinib—Myalgia—Betamethasone—systemic lupus erythematosus	5.73e-05	0.000664	CcSEcCtD
Ponatinib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	5.71e-05	0.000662	CcSEcCtD
Ponatinib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	5.71e-05	0.000662	CcSEcCtD
Ponatinib—ABCB1—central nervous system—systemic lupus erythematosus	5.69e-05	0.000918	CbGeAlD
Ponatinib—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	5.66e-05	0.000655	CcSEcCtD
Ponatinib—Haemoglobin—Methotrexate—systemic lupus erythematosus	5.65e-05	0.000655	CcSEcCtD
Ponatinib—Pain—Prednisolone—systemic lupus erythematosus	5.63e-05	0.000652	CcSEcCtD
Ponatinib—Haemorrhage—Methotrexate—systemic lupus erythematosus	5.62e-05	0.000652	CcSEcCtD
Ponatinib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	5.58e-05	0.000647	CcSEcCtD
Ponatinib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	5.57e-05	0.000646	CcSEcCtD
Ponatinib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	5.57e-05	0.000646	CcSEcCtD
Ponatinib—Nausea—Leflunomide—systemic lupus erythematosus	5.56e-05	0.000645	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	5.55e-05	0.000643	CcSEcCtD
Ponatinib—Fatigue—Hydrocortisone—systemic lupus erythematosus	5.54e-05	0.000642	CcSEcCtD
Ponatinib—Vision blurred—Prednisone—systemic lupus erythematosus	5.52e-05	0.00064	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	5.51e-05	0.000639	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	5.5e-05	0.000637	CcSEcCtD
Ponatinib—Pain—Hydrocortisone—systemic lupus erythematosus	5.49e-05	0.000637	CcSEcCtD
Ponatinib—Oedema—Dexamethasone—systemic lupus erythematosus	5.49e-05	0.000636	CcSEcCtD
Ponatinib—Oedema—Betamethasone—systemic lupus erythematosus	5.49e-05	0.000636	CcSEcCtD
Ponatinib—Insomnia—Triamcinolone—systemic lupus erythematosus	5.47e-05	0.000634	CcSEcCtD
Ponatinib—Insomnia—Methylprednisolone—systemic lupus erythematosus	5.46e-05	0.000633	CcSEcCtD
Ponatinib—Infection—Betamethasone—systemic lupus erythematosus	5.45e-05	0.000632	CcSEcCtD
Ponatinib—Infection—Dexamethasone—systemic lupus erythematosus	5.45e-05	0.000632	CcSEcCtD
Ponatinib—Paraesthesia—Triamcinolone—systemic lupus erythematosus	5.43e-05	0.000629	CcSEcCtD
Ponatinib—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	5.42e-05	0.000628	CcSEcCtD
Ponatinib—Visual impairment—Methotrexate—systemic lupus erythematosus	5.42e-05	0.000628	CcSEcCtD
Ponatinib—Anaemia—Prednisone—systemic lupus erythematosus	5.41e-05	0.000627	CcSEcCtD
Ponatinib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	5.39e-05	0.000625	CcSEcCtD
Ponatinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	5.38e-05	0.000624	CcSEcCtD
Ponatinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	5.38e-05	0.000624	CcSEcCtD
Ponatinib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	5.37e-05	0.000623	CcSEcCtD
Ponatinib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	5.37e-05	0.000623	CcSEcCtD
Ponatinib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	5.32e-05	0.000617	CcSEcCtD
Ponatinib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	5.31e-05	0.000616	CcSEcCtD
Ponatinib—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	5.31e-05	0.000615	CcSEcCtD
Ponatinib—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	5.31e-05	0.000615	CcSEcCtD
Ponatinib—Eye disorder—Methotrexate—systemic lupus erythematosus	5.25e-05	0.000609	CcSEcCtD
Ponatinib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	5.25e-05	0.000609	CcSEcCtD
Ponatinib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	5.22e-05	0.000605	CcSEcCtD
Ponatinib—Fatigue—Triamcinolone—systemic lupus erythematosus	5.22e-05	0.000604	CcSEcCtD
Ponatinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	5.2e-05	0.000603	CcSEcCtD
Ponatinib—Asthenia—Cyclosporine—systemic lupus erythematosus	5.19e-05	0.000601	CcSEcCtD
Ponatinib—Pain—Triamcinolone—systemic lupus erythematosus	5.17e-05	0.000599	CcSEcCtD
Ponatinib—Pruritus—Cyclosporine—systemic lupus erythematosus	5.11e-05	0.000593	CcSEcCtD
Ponatinib—Angiopathy—Methotrexate—systemic lupus erythematosus	5.1e-05	0.000591	CcSEcCtD
Ponatinib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	5.08e-05	0.000589	CcSEcCtD
Ponatinib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.08e-05	0.000589	CcSEcCtD
Ponatinib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	5.07e-05	0.000587	CcSEcCtD
Ponatinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.06e-05	0.000586	CcSEcCtD
Ponatinib—Hypertension—Prednisone—systemic lupus erythematosus	5.06e-05	0.000586	CcSEcCtD
Ponatinib—Chills—Methotrexate—systemic lupus erythematosus	5.05e-05	0.000585	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	5e-05	0.00058	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	5e-05	0.00058	CcSEcCtD
Ponatinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.99e-05	0.000578	CcSEcCtD
Ponatinib—Myalgia—Prednisone—systemic lupus erythematosus	4.99e-05	0.000578	CcSEcCtD
Ponatinib—Arthralgia—Prednisone—systemic lupus erythematosus	4.99e-05	0.000578	CcSEcCtD
Ponatinib—Alopecia—Methotrexate—systemic lupus erythematosus	4.97e-05	0.000576	CcSEcCtD
Ponatinib—Insomnia—Dexamethasone—systemic lupus erythematosus	4.96e-05	0.000575	CcSEcCtD
Ponatinib—Insomnia—Betamethasone—systemic lupus erythematosus	4.96e-05	0.000575	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.95e-05	0.000574	CcSEcCtD
Ponatinib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.95e-05	0.000573	CcSEcCtD
Ponatinib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.94e-05	0.000572	CcSEcCtD
Ponatinib—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.93e-05	0.000571	CcSEcCtD
Ponatinib—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.93e-05	0.000571	CcSEcCtD
Ponatinib—Mental disorder—Methotrexate—systemic lupus erythematosus	4.93e-05	0.000571	CcSEcCtD
Ponatinib—Erythema—Methotrexate—systemic lupus erythematosus	4.89e-05	0.000567	CcSEcCtD
Ponatinib—Malnutrition—Methotrexate—systemic lupus erythematosus	4.89e-05	0.000567	CcSEcCtD
Ponatinib—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.83e-05	0.00056	CcSEcCtD
Ponatinib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.83e-05	0.00056	CcSEcCtD
Ponatinib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.82e-05	0.000559	CcSEcCtD
Ponatinib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.78e-05	0.000554	CcSEcCtD
Ponatinib—Dizziness—Cyclosporine—systemic lupus erythematosus	4.78e-05	0.000554	CcSEcCtD
Ponatinib—Oedema—Prednisone—systemic lupus erythematosus	4.78e-05	0.000554	CcSEcCtD
Ponatinib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.77e-05	0.000553	CcSEcCtD
Ponatinib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.77e-05	0.000553	CcSEcCtD
Ponatinib—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.77e-05	0.000553	CcSEcCtD
Ponatinib—Infection—Prednisone—systemic lupus erythematosus	4.75e-05	0.00055	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.74e-05	0.000549	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.74e-05	0.000549	CcSEcCtD
Ponatinib—Back pain—Methotrexate—systemic lupus erythematosus	4.73e-05	0.000549	CcSEcCtD
Ponatinib—Fatigue—Dexamethasone—systemic lupus erythematosus	4.73e-05	0.000548	CcSEcCtD
Ponatinib—Fatigue—Betamethasone—systemic lupus erythematosus	4.73e-05	0.000548	CcSEcCtD
Ponatinib—Pain—Dexamethasone—systemic lupus erythematosus	4.69e-05	0.000544	CcSEcCtD
Ponatinib—Pain—Betamethasone—systemic lupus erythematosus	4.69e-05	0.000544	CcSEcCtD
Ponatinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.69e-05	0.000543	CcSEcCtD
Ponatinib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.66e-05	0.00054	CcSEcCtD
Ponatinib—Skin disorder—Prednisone—systemic lupus erythematosus	4.64e-05	0.000538	CcSEcCtD
Ponatinib—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.62e-05	0.000536	CcSEcCtD
Ponatinib—Vision blurred—Methotrexate—systemic lupus erythematosus	4.61e-05	0.000535	CcSEcCtD
Ponatinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.61e-05	0.000534	CcSEcCtD
Ponatinib—Vomiting—Cyclosporine—systemic lupus erythematosus	4.6e-05	0.000533	CcSEcCtD
Ponatinib—Rash—Cyclosporine—systemic lupus erythematosus	4.56e-05	0.000528	CcSEcCtD
Ponatinib—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.55e-05	0.000528	CcSEcCtD
Ponatinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.55e-05	0.000527	CcSEcCtD
Ponatinib—Headache—Cyclosporine—systemic lupus erythematosus	4.53e-05	0.000525	CcSEcCtD
Ponatinib—Anaemia—Methotrexate—systemic lupus erythematosus	4.52e-05	0.000524	CcSEcCtD
Ponatinib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.49e-05	0.00052	CcSEcCtD
Ponatinib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.49e-05	0.00052	CcSEcCtD
Ponatinib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.48e-05	0.00052	CcSEcCtD
Ponatinib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.45e-05	0.000515	CcSEcCtD
Ponatinib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.44e-05	0.000515	CcSEcCtD
Ponatinib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.42e-05	0.000512	CcSEcCtD
Ponatinib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.4e-05	0.000509	CcSEcCtD
Ponatinib—Leukopenia—Methotrexate—systemic lupus erythematosus	4.38e-05	0.000508	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.35e-05	0.000505	CcSEcCtD
Ponatinib—Dizziness—Prednisolone—systemic lupus erythematosus	4.35e-05	0.000504	CcSEcCtD
Ponatinib—Asthenia—Triamcinolone—systemic lupus erythematosus	4.34e-05	0.000503	CcSEcCtD
Ponatinib—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.34e-05	0.000503	CcSEcCtD
Ponatinib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.34e-05	0.000503	CcSEcCtD
Ponatinib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.34e-05	0.000503	CcSEcCtD
Ponatinib—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.34e-05	0.000503	CcSEcCtD
Ponatinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.33e-05	0.000502	CcSEcCtD
Ponatinib—Insomnia—Prednisone—systemic lupus erythematosus	4.32e-05	0.000501	CcSEcCtD
Ponatinib—Nausea—Cyclosporine—systemic lupus erythematosus	4.29e-05	0.000498	CcSEcCtD
Ponatinib—Paraesthesia—Prednisone—systemic lupus erythematosus	4.29e-05	0.000497	CcSEcCtD
Ponatinib—Pruritus—Triamcinolone—systemic lupus erythematosus	4.28e-05	0.000496	CcSEcCtD
Ponatinib—Cough—Methotrexate—systemic lupus erythematosus	4.27e-05	0.000495	CcSEcCtD
Ponatinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.27e-05	0.000495	CcSEcCtD
Ponatinib—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.25e-05	0.000492	CcSEcCtD
Ponatinib—Dyspepsia—Prednisone—systemic lupus erythematosus	4.21e-05	0.000488	CcSEcCtD
Ponatinib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.19e-05	0.000485	CcSEcCtD
Ponatinib—Arthralgia—Methotrexate—systemic lupus erythematosus	4.17e-05	0.000483	CcSEcCtD
Ponatinib—Myalgia—Methotrexate—systemic lupus erythematosus	4.17e-05	0.000483	CcSEcCtD
Ponatinib—Decreased appetite—Prednisone—systemic lupus erythematosus	4.16e-05	0.000482	CcSEcCtD
Ponatinib—Rash—Prednisolone—systemic lupus erythematosus	4.15e-05	0.000481	CcSEcCtD
Ponatinib—Dermatitis—Prednisolone—systemic lupus erythematosus	4.14e-05	0.00048	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	4.14e-05	0.00048	CcSEcCtD
Ponatinib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.13e-05	0.000479	CcSEcCtD
Ponatinib—Fatigue—Prednisone—systemic lupus erythematosus	4.12e-05	0.000478	CcSEcCtD
Ponatinib—Headache—Prednisolone—systemic lupus erythematosus	4.12e-05	0.000478	CcSEcCtD
Ponatinib—Constipation—Prednisone—systemic lupus erythematosus	4.09e-05	0.000474	CcSEcCtD
Ponatinib—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.08e-05	0.000473	CcSEcCtD
Ponatinib—Rash—Hydrocortisone—systemic lupus erythematosus	4.05e-05	0.000469	CcSEcCtD
Ponatinib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.05e-05	0.000469	CcSEcCtD
Ponatinib—Headache—Hydrocortisone—systemic lupus erythematosus	4.02e-05	0.000466	CcSEcCtD
Ponatinib—Dizziness—Triamcinolone—systemic lupus erythematosus	4e-05	0.000464	CcSEcCtD
Ponatinib—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.99e-05	0.000463	CcSEcCtD
Ponatinib—Infection—Methotrexate—systemic lupus erythematosus	3.97e-05	0.00046	CcSEcCtD
Ponatinib—Asthenia—Dexamethasone—systemic lupus erythematosus	3.94e-05	0.000456	CcSEcCtD
Ponatinib—Asthenia—Betamethasone—systemic lupus erythematosus	3.94e-05	0.000456	CcSEcCtD
Ponatinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.92e-05	0.000454	CcSEcCtD
Ponatinib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	3.91e-05	0.000453	CcSEcCtD
Ponatinib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.91e-05	0.000453	CcSEcCtD
Ponatinib—Nausea—Prednisolone—systemic lupus erythematosus	3.91e-05	0.000453	CcSEcCtD
Ponatinib—Pruritus—Betamethasone—systemic lupus erythematosus	3.88e-05	0.00045	CcSEcCtD
Ponatinib—Pruritus—Dexamethasone—systemic lupus erythematosus	3.88e-05	0.00045	CcSEcCtD
Ponatinib—Skin disorder—Methotrexate—systemic lupus erythematosus	3.88e-05	0.00045	CcSEcCtD
Ponatinib—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000448	CcSEcCtD
Ponatinib—Vomiting—Triamcinolone—systemic lupus erythematosus	3.85e-05	0.000446	CcSEcCtD
Ponatinib—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.84e-05	0.000445	CcSEcCtD
Ponatinib—Nausea—Hydrocortisone—systemic lupus erythematosus	3.82e-05	0.000442	CcSEcCtD
Ponatinib—Rash—Triamcinolone—systemic lupus erythematosus	3.81e-05	0.000442	CcSEcCtD
Ponatinib—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.81e-05	0.000442	CcSEcCtD
Ponatinib—Rash—Methylprednisolone—systemic lupus erythematosus	3.81e-05	0.000441	CcSEcCtD
Ponatinib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.8e-05	0.000441	CcSEcCtD
Ponatinib—Headache—Triamcinolone—systemic lupus erythematosus	3.79e-05	0.000439	CcSEcCtD
Ponatinib—Headache—Methylprednisolone—systemic lupus erythematosus	3.78e-05	0.000438	CcSEcCtD
Ponatinib—Abdominal pain—Prednisone—systemic lupus erythematosus	3.78e-05	0.000438	CcSEcCtD
Ponatinib—Body temperature increased—Prednisone—systemic lupus erythematosus	3.78e-05	0.000438	CcSEcCtD
Ponatinib—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.76e-05	0.000435	CcSEcCtD
Ponatinib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.76e-05	0.000435	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.64e-05	0.000422	CcSEcCtD
Ponatinib—Dizziness—Betamethasone—systemic lupus erythematosus	3.63e-05	0.000421	CcSEcCtD
Ponatinib—Dizziness—Dexamethasone—systemic lupus erythematosus	3.63e-05	0.000421	CcSEcCtD
Ponatinib—Insomnia—Methotrexate—systemic lupus erythematosus	3.61e-05	0.000419	CcSEcCtD
Ponatinib—Nausea—Triamcinolone—systemic lupus erythematosus	3.59e-05	0.000416	CcSEcCtD
Ponatinib—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.59e-05	0.000416	CcSEcCtD
Ponatinib—Nausea—Methylprednisolone—systemic lupus erythematosus	3.59e-05	0.000415	CcSEcCtD
Ponatinib—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.56e-05	0.000413	CcSEcCtD
Ponatinib—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.52e-05	0.000408	CcSEcCtD
Ponatinib—Vomiting—Betamethasone—systemic lupus erythematosus	3.49e-05	0.000404	CcSEcCtD
Ponatinib—Vomiting—Dexamethasone—systemic lupus erythematosus	3.49e-05	0.000404	CcSEcCtD
Ponatinib—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.47e-05	0.000402	CcSEcCtD
Ponatinib—Rash—Dexamethasone—systemic lupus erythematosus	3.46e-05	0.000401	CcSEcCtD
Ponatinib—Rash—Betamethasone—systemic lupus erythematosus	3.46e-05	0.000401	CcSEcCtD
Ponatinib—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.46e-05	0.000401	CcSEcCtD
Ponatinib—Dermatitis—Betamethasone—systemic lupus erythematosus	3.46e-05	0.000401	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.45e-05	0.0004	CcSEcCtD
Ponatinib—Fatigue—Methotrexate—systemic lupus erythematosus	3.44e-05	0.000399	CcSEcCtD
Ponatinib—Headache—Betamethasone—systemic lupus erythematosus	3.44e-05	0.000398	CcSEcCtD
Ponatinib—Headache—Dexamethasone—systemic lupus erythematosus	3.44e-05	0.000398	CcSEcCtD
Ponatinib—Asthenia—Prednisone—systemic lupus erythematosus	3.43e-05	0.000397	CcSEcCtD
Ponatinib—Pain—Methotrexate—systemic lupus erythematosus	3.42e-05	0.000396	CcSEcCtD
Ponatinib—Pruritus—Prednisone—systemic lupus erythematosus	3.38e-05	0.000392	CcSEcCtD
Ponatinib—Diarrhoea—Prednisone—systemic lupus erythematosus	3.27e-05	0.000379	CcSEcCtD
Ponatinib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.27e-05	0.000379	CcSEcCtD
Ponatinib—Nausea—Betamethasone—systemic lupus erythematosus	3.26e-05	0.000378	CcSEcCtD
Ponatinib—Nausea—Dexamethasone—systemic lupus erythematosus	3.26e-05	0.000378	CcSEcCtD
Ponatinib—Dizziness—Prednisone—systemic lupus erythematosus	3.16e-05	0.000366	CcSEcCtD
Ponatinib—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000366	CcSEcCtD
Ponatinib—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000366	CcSEcCtD
Ponatinib—Vomiting—Prednisone—systemic lupus erythematosus	3.04e-05	0.000352	CcSEcCtD
Ponatinib—Rash—Prednisone—systemic lupus erythematosus	3.01e-05	0.000349	CcSEcCtD
Ponatinib—Dermatitis—Prednisone—systemic lupus erythematosus	3.01e-05	0.000349	CcSEcCtD
Ponatinib—Headache—Prednisone—systemic lupus erythematosus	2.99e-05	0.000347	CcSEcCtD
Ponatinib—Asthenia—Methotrexate—systemic lupus erythematosus	2.87e-05	0.000332	CcSEcCtD
Ponatinib—Nausea—Prednisone—systemic lupus erythematosus	2.84e-05	0.000329	CcSEcCtD
Ponatinib—Pruritus—Methotrexate—systemic lupus erythematosus	2.83e-05	0.000328	CcSEcCtD
Ponatinib—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.73e-05	0.000317	CcSEcCtD
Ponatinib—Dizziness—Methotrexate—systemic lupus erythematosus	2.64e-05	0.000306	CcSEcCtD
Ponatinib—Vomiting—Methotrexate—systemic lupus erythematosus	2.54e-05	0.000294	CcSEcCtD
Ponatinib—Rash—Methotrexate—systemic lupus erythematosus	2.52e-05	0.000292	CcSEcCtD
Ponatinib—Dermatitis—Methotrexate—systemic lupus erythematosus	2.52e-05	0.000292	CcSEcCtD
Ponatinib—Headache—Methotrexate—systemic lupus erythematosus	2.5e-05	0.00029	CcSEcCtD
Ponatinib—Nausea—Methotrexate—systemic lupus erythematosus	2.37e-05	0.000275	CcSEcCtD
Ponatinib—ABL1—Immune System—IFNG—systemic lupus erythematosus	2.76e-06	2.36e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—TLR4—systemic lupus erythematosus	2.76e-06	2.36e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCR5—systemic lupus erythematosus	2.76e-06	2.35e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—HLA-DRB1—systemic lupus erythematosus	2.76e-06	2.35e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—EP300—systemic lupus erythematosus	2.76e-06	2.35e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.73e-06	2.33e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.72e-06	2.32e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CD80—systemic lupus erythematosus	2.72e-06	2.32e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TGFB1—systemic lupus erythematosus	2.72e-06	2.32e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—NOS3—systemic lupus erythematosus	2.7e-06	2.31e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—EP300—systemic lupus erythematosus	2.7e-06	2.3e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—C3—systemic lupus erythematosus	2.7e-06	2.3e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—F2—systemic lupus erythematosus	2.69e-06	2.3e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—F2—systemic lupus erythematosus	2.69e-06	2.29e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD4—systemic lupus erythematosus	2.68e-06	2.29e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP9—systemic lupus erythematosus	2.68e-06	2.28e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD4—systemic lupus erythematosus	2.67e-06	2.28e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.67e-06	2.27e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TGFB1—systemic lupus erythematosus	2.66e-06	2.27e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CD80—systemic lupus erythematosus	2.66e-06	2.27e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—EP300—systemic lupus erythematosus	2.65e-06	2.26e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CDKN1B—systemic lupus erythematosus	2.65e-06	2.26e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CDKN1A—systemic lupus erythematosus	2.65e-06	2.26e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PRL—systemic lupus erythematosus	2.64e-06	2.25e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CDKN1B—systemic lupus erythematosus	2.64e-06	2.25e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CDKN1A—systemic lupus erythematosus	2.64e-06	2.25e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—CDKN1A—systemic lupus erythematosus	2.62e-06	2.23e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.6e-06	2.22e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CD80—systemic lupus erythematosus	2.58e-06	2.2e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CCL2—systemic lupus erythematosus	2.58e-06	2.2e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CD80—systemic lupus erythematosus	2.58e-06	2.2e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—CDKN1A—systemic lupus erythematosus	2.57e-06	2.19e-05	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL6—systemic lupus erythematosus	2.57e-06	2.19e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD80—systemic lupus erythematosus	2.55e-06	2.17e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—EP300—systemic lupus erythematosus	2.54e-06	2.16e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—systemic lupus erythematosus	2.54e-06	2.16e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CCL2—systemic lupus erythematosus	2.53e-06	2.16e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CDKN1B—systemic lupus erythematosus	2.52e-06	2.15e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.52e-06	2.15e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—EP300—systemic lupus erythematosus	2.52e-06	2.15e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—EP300—systemic lupus erythematosus	2.51e-06	2.14e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CDKN1B—systemic lupus erythematosus	2.51e-06	2.14e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—EP300—systemic lupus erythematosus	2.49e-06	2.13e-05	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—IL6—systemic lupus erythematosus	2.49e-06	2.12e-05	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—IL6—systemic lupus erythematosus	2.48e-06	2.11e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTGS2—systemic lupus erythematosus	2.47e-06	2.11e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL2—systemic lupus erythematosus	2.47e-06	2.1e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL2—systemic lupus erythematosus	2.46e-06	2.1e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL2—systemic lupus erythematosus	2.46e-06	2.09e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—EP300—systemic lupus erythematosus	2.45e-06	2.09e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—CDKN1A—systemic lupus erythematosus	2.44e-06	2.08e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—CDKN1A—systemic lupus erythematosus	2.44e-06	2.08e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—TYK2—systemic lupus erythematosus	2.43e-06	2.07e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.4e-06	2.05e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.4e-06	2.05e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CCL2—systemic lupus erythematosus	2.39e-06	2.04e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—JAK1—systemic lupus erythematosus	2.39e-06	2.04e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—IL6—systemic lupus erythematosus	2.37e-06	2.02e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—F2—systemic lupus erythematosus	2.37e-06	2.02e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	2.36e-06	2.01e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CD80—systemic lupus erythematosus	2.35e-06	2.01e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TYK2—systemic lupus erythematosus	2.34e-06	1.99e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP9—systemic lupus erythematosus	2.33e-06	1.99e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—CDKN1A—systemic lupus erythematosus	2.33e-06	1.98e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.32e-06	1.98e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—EP300—systemic lupus erythematosus	2.32e-06	1.98e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—EP300—systemic lupus erythematosus	2.32e-06	1.98e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CDKN1A—systemic lupus erythematosus	2.32e-06	1.98e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TYK2—systemic lupus erythematosus	2.3e-06	1.96e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NOS3—systemic lupus erythematosus	2.3e-06	1.96e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.28e-06	1.94e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFNG—systemic lupus erythematosus	2.28e-06	1.94e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CD80—systemic lupus erythematosus	2.27e-06	1.94e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCR5—systemic lupus erythematosus	2.26e-06	1.93e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NOS3—systemic lupus erythematosus	2.25e-06	1.92e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—systemic lupus erythematosus	2.25e-06	1.92e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TYK2—systemic lupus erythematosus	2.24e-06	1.91e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.23e-06	1.9e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—EP300—systemic lupus erythematosus	2.21e-06	1.89e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—C3—systemic lupus erythematosus	2.21e-06	1.89e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—EP300—systemic lupus erythematosus	2.21e-06	1.89e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.21e-06	1.88e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—EP300—systemic lupus erythematosus	2.2e-06	1.88e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS3—systemic lupus erythematosus	2.2e-06	1.88e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD4—systemic lupus erythematosus	2.2e-06	1.87e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.18e-06	1.86e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TYK2—systemic lupus erythematosus	2.17e-06	1.85e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—systemic lupus erythematosus	2.17e-06	1.85e-05	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.16e-06	1.84e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—TYK2—systemic lupus erythematosus	2.15e-06	1.84e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.14e-06	1.82e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NOS3—systemic lupus erythematosus	2.13e-06	1.82e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—systemic lupus erythematosus	2.13e-06	1.82e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—JAK1—systemic lupus erythematosus	2.11e-06	1.8e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCL2—systemic lupus erythematosus	2.11e-06	1.8e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.09e-06	1.79e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	2.08e-06	1.77e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CDKN1B—systemic lupus erythematosus	2.07e-06	1.76e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—EP300—systemic lupus erythematosus	2.06e-06	1.75e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—systemic lupus erythematosus	2.05e-06	1.74e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	2.04e-06	1.74e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—systemic lupus erythematosus	2.04e-06	1.74e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CD4—systemic lupus erythematosus	2.03e-06	1.73e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL2—systemic lupus erythematosus	2.02e-06	1.72e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—systemic lupus erythematosus	2.02e-06	1.72e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—systemic lupus erythematosus	2.02e-06	1.72e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—systemic lupus erythematosus	2.02e-06	1.72e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—systemic lupus erythematosus	2.02e-06	1.72e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCR5—systemic lupus erythematosus	2e-06	1.71e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.99e-06	1.7e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TYK2—systemic lupus erythematosus	1.99e-06	1.69e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.98e-06	1.68e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—C3—systemic lupus erythematosus	1.96e-06	1.67e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.96e-06	1.67e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.95e-06	1.67e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS3—systemic lupus erythematosus	1.95e-06	1.66e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD4—systemic lupus erythematosus	1.95e-06	1.66e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL2—systemic lupus erythematosus	1.95e-06	1.66e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—F2—systemic lupus erythematosus	1.94e-06	1.66e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.92e-06	1.64e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TYK2—systemic lupus erythematosus	1.92e-06	1.64e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL2—systemic lupus erythematosus	1.91e-06	1.63e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CDKN1B—systemic lupus erythematosus	1.91e-06	1.63e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CDKN1A—systemic lupus erythematosus	1.91e-06	1.63e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.89e-06	1.62e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NOS3—systemic lupus erythematosus	1.88e-06	1.6e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ALB—systemic lupus erythematosus	1.87e-06	1.59e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CD80—systemic lupus erythematosus	1.86e-06	1.59e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.85e-06	1.58e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.85e-06	1.58e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.84e-06	1.57e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.84e-06	1.56e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CDKN1B—systemic lupus erythematosus	1.83e-06	1.56e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—EP300—systemic lupus erythematosus	1.82e-06	1.55e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL2—systemic lupus erythematosus	1.81e-06	1.55e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL2—systemic lupus erythematosus	1.81e-06	1.54e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—systemic lupus erythematosus	1.81e-06	1.54e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—systemic lupus erythematosus	1.81e-06	1.54e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.8e-06	1.54e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CD4—systemic lupus erythematosus	1.8e-06	1.53e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL2—systemic lupus erythematosus	1.79e-06	1.53e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	1.79e-06	1.52e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—systemic lupus erythematosus	1.78e-06	1.52e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	1.78e-06	1.52e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—systemic lupus erythematosus	1.77e-06	1.51e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—CDKN1A—systemic lupus erythematosus	1.76e-06	1.5e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—EP300—systemic lupus erythematosus	1.75e-06	1.49e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—systemic lupus erythematosus	1.74e-06	1.48e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCL2—systemic lupus erythematosus	1.73e-06	1.48e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—F2—systemic lupus erythematosus	1.72e-06	1.47e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.72e-06	1.46e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—EP300—systemic lupus erythematosus	1.71e-06	1.46e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—systemic lupus erythematosus	1.71e-06	1.46e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.71e-06	1.46e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.71e-06	1.45e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CDKN1B—systemic lupus erythematosus	1.69e-06	1.44e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CDKN1A—systemic lupus erythematosus	1.69e-06	1.44e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	1.68e-06	1.43e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—EP300—systemic lupus erythematosus	1.68e-06	1.43e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—systemic lupus erythematosus	1.66e-06	1.42e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.65e-06	1.41e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—systemic lupus erythematosus	1.65e-06	1.41e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CD80—systemic lupus erythematosus	1.65e-06	1.41e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—systemic lupus erythematosus	1.64e-06	1.4e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	1.63e-06	1.39e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—systemic lupus erythematosus	1.63e-06	1.39e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.63e-06	1.39e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.63e-06	1.39e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.62e-06	1.38e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—EP300—systemic lupus erythematosus	1.62e-06	1.38e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—EP300—systemic lupus erythematosus	1.61e-06	1.37e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—systemic lupus erythematosus	1.6e-06	1.37e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL2—systemic lupus erythematosus	1.6e-06	1.36e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TYK2—systemic lupus erythematosus	1.57e-06	1.34e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—CDKN1A—systemic lupus erythematosus	1.56e-06	1.33e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOS3—systemic lupus erythematosus	1.54e-06	1.32e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.54e-06	1.31e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.54e-06	1.31e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—systemic lupus erythematosus	1.53e-06	1.31e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—systemic lupus erythematosus	1.52e-06	1.3e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—systemic lupus erythematosus	1.52e-06	1.29e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.52e-06	1.29e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—systemic lupus erythematosus	1.51e-06	1.29e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.5e-06	1.28e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.49e-06	1.27e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	1.49e-06	1.27e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—EP300—systemic lupus erythematosus	1.48e-06	1.27e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—systemic lupus erythematosus	1.46e-06	1.24e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—systemic lupus erythematosus	1.45e-06	1.24e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—systemic lupus erythematosus	1.45e-06	1.24e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—systemic lupus erythematosus	1.44e-06	1.23e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—EP300—systemic lupus erythematosus	1.43e-06	1.22e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.41e-06	1.21e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.41e-06	1.2e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TYK2—systemic lupus erythematosus	1.39e-06	1.19e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOS3—systemic lupus erythematosus	1.37e-06	1.16e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—EP300—systemic lupus erythematosus	1.36e-06	1.16e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.36e-06	1.16e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	1.34e-06	1.14e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.34e-06	1.14e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL2—systemic lupus erythematosus	1.31e-06	1.12e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—systemic lupus erythematosus	1.29e-06	1.1e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	1.29e-06	1.1e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	1.28e-06	1.09e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.24e-06	1.06e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—systemic lupus erythematosus	1.24e-06	1.06e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.23e-06	1.05e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—systemic lupus erythematosus	1.19e-06	1.01e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.18e-06	1.01e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—EP300—systemic lupus erythematosus	1.17e-06	1e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	1.17e-06	9.99e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	1.16e-06	9.89e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL2—systemic lupus erythematosus	1.16e-06	9.87e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—systemic lupus erythematosus	1.14e-06	9.75e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.12e-06	9.58e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—systemic lupus erythematosus	1.12e-06	9.58e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.11e-06	9.48e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.11e-06	9.46e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—systemic lupus erythematosus	1.1e-06	9.36e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.1e-06	9.35e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—systemic lupus erythematosus	1.1e-06	9.34e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.09e-06	9.31e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—systemic lupus erythematosus	1.07e-06	9.09e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—systemic lupus erythematosus	1.06e-06	9.07e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.06e-06	9.03e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—systemic lupus erythematosus	1.05e-06	8.98e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EP300—systemic lupus erythematosus	1.04e-06	8.86e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.02e-06	8.7e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.01e-06	8.65e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.01e-06	8.61e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VEGFA—systemic lupus erythematosus	9.84e-07	8.39e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	9.74e-07	8.31e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—systemic lupus erythematosus	9.72e-07	8.29e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	9.66e-07	8.24e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	9.52e-07	8.12e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—systemic lupus erythematosus	9.38e-07	8e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	9.11e-07	7.76e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.03e-07	7.7e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	8.84e-07	7.54e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	8.44e-07	7.19e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	8.33e-07	7.1e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—systemic lupus erythematosus	7.69e-07	6.55e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	7.35e-07	6.27e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	6.93e-07	5.91e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	6.92e-07	5.9e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—systemic lupus erythematosus	6.81e-07	5.8e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	6.22e-07	5.31e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	5.95e-07	5.08e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	5.45e-07	4.64e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	4.53e-07	3.86e-06	CbGpPWpGaD
